Found 7 matching trials
A Placebo- and Active Controlled Study of Preladenant in Subjects With Moderate to Severe Parkinson's Disease (P04938)
PHASE3When a patient with Parkinson's disease (PD) is initially treated with L-do...
Location
Multiple Locations
Placebo Controlled Study of Preladenant in Participants With Moderate to Severe Parkinson's Disease (P07037)
PHASE3This is a study of the efficacy and safety of preladenant in adult particip...
Location
Multiple Locations
A Study to Assess Pharmacokinetics (PK) of Preladenant in Participants With Chronic Renal Impairment (CRI) (P06512)
PHASE1This is a two part study to compare the PK of preladenant administered to p...
Location
Multiple Locations
A Dose Finding Study of Preladenant (SCH 420814) for the Treatment of Parkinson's Disease (PD) in Japanese Patients (P06402)
PHASE2This study is to evaluate the efficacy of a range of preladenant doses comp...
Location
Multiple Locations
A Placebo- and Active-Controlled Study of Preladenant in Early Parkinson's Disease (PD) (P05664)
PHASE3This is a one year, 2-part study to determine the efficacy and safety of pr...
Location
Multiple Locations
An Active-Controlled Extension Study to NCT01155466 [P04938] and NCT01227265 [P07037] (P06153)
PHASE3The primary purpose of this extension study is to assess the long-term safe...
Location
Multiple Locations
A Study to Assess Pharmacokinetics of Preladenant in Participants With Chronic Hepatic Impairment (P06513)
PHASE1The purpose of this study is to compare the pharmacokinetics (PK) of prelad...
Location
Multiple Locations